Role of CD19 and specific KIT‐D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities

High‐dose cytarabine (Ara‐C) has been reported with increased treatment‐related mortality, whereas few data are available concerning intermediate‐dose Ara‐C for induction of acute myeloid leukemia (AML) with t(8;21) translocation. We retrospectively analyzed factors impacting complete remission (CR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Biao, Yang, Bin, Ling, Yun, Zhang, Jihong, Hua, Xiaoying, Gu, Weiying, Yan, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897948/
https://www.ncbi.nlm.nih.gov/pubmed/33382538
http://dx.doi.org/10.1002/cam4.3705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897948/
https://www.ncbi.nlm.nih.gov/pubmed/33382538
http://dx.doi.org/10.1002/cam4.3705

Ejemplares similares